These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 31762191

  • 1. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
    Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D.
    J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191
    [Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
    Iwase R, Haruki K, Fujiwara Y, Furukawa K, Shiba H, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Surg Res; 2013 Sep; 184(1):605-12. PubMed ID: 23830367
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.
    Zhou C, Qian W, Ma J, Cheng L, Jiang Z, Yan B, Li J, Duan W, Sun L, Cao J, Wang F, Wu E, Wu Z, Ma Q, Li X.
    Cell Prolif; 2019 Jan; 52(1):e12514. PubMed ID: 30341797
    [Abstract] [Full Text] [Related]

  • 4. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
    Yu Y, Wang J, Xia N, Li B, Jiang X.
    Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
    Wang FT, Wang H, Wang QW, Pan MS, Li XP, Sun W, Fan YZ.
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):221-232. PubMed ID: 32654071
    [Abstract] [Full Text] [Related]

  • 6. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.
    Zhang DC, Liu JL, Ding YB, Xia JG, Chen GY.
    Acta Pharmacol Sin; 2013 Feb; 34(2):301-8. PubMed ID: 23274410
    [Abstract] [Full Text] [Related]

  • 7. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α.
    Gao H, Xie J, Peng J, Han Y, Jiang Q, Han M, Wang C.
    Exp Cell Res; 2015 Mar 15; 332(2):236-46. PubMed ID: 25499970
    [Abstract] [Full Text] [Related]

  • 8. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK, Lung RW, Dawson CW, Young LS, Ko CW, Yeung WW, Kang W, To KF, Lo KW.
    J Pathol; 2018 Oct 15; 246(2):180-190. PubMed ID: 29968360
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice.
    Mita Y, Ajiki T, Kamigaki T, Okazaki T, Hori H, Horiuchi H, Hirata K, Fujita T, Fujimori T, Kuroda Y.
    Ann Surg Oncol; 2007 Apr 15; 14(4):1374-80. PubMed ID: 17235714
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
    Zhang GF, Wu JC, Wang HY, Jiang WD, Qiu L.
    Biosci Rep; 2020 Sep 30; 40(9):. PubMed ID: 32869841
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo.
    Wang W, Hu Z, Huang Y, Zheng H, Sun Q, Yang Q, Zhang Y, Zhang L, Wang W.
    Biomed Res Int; 2019 Sep 30; 2019():9205851. PubMed ID: 31019975
    [Abstract] [Full Text] [Related]

  • 12. Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis.
    Meng H, Shen M, Li J, Zhang R, Li X, Zhao L, Huang G, Liu J.
    Eur J Pharmacol; 2021 Sep 05; 906():174280. PubMed ID: 34174265
    [Abstract] [Full Text] [Related]

  • 13. DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.
    Feng T, Li S, Zhao G, Li Q, Yuan H, Zhang J, Gu R, Ou D, Guo Y, Kou Q, Wang Q, Li K, Lin P.
    Cell Oncol (Dordr); 2023 Oct 05; 46(5):1235-1252. PubMed ID: 37052853
    [Abstract] [Full Text] [Related]

  • 14. Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer.
    Ye J, Qi L, Du Z, Yu L, Chen K, Li R, Feng R, Zhai W.
    Aging (Albany NY); 2021 Feb 11; 13(4):5607-5620. PubMed ID: 33591948
    [Abstract] [Full Text] [Related]

  • 15. Brexpiprazole suppresses cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in colorectal cancer.
    Li T, Liu X, Long X, Li Y, Xiang J, Lv Y, Zhao X, Shi S, Chen W.
    Environ Toxicol; 2023 Oct 11; 38(10):2352-2360. PubMed ID: 37347510
    [Abstract] [Full Text] [Related]

  • 16. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y, Wu X, Zhou Y, Jiang H, Pan S, Sun B.
    Cancer Prev Res (Phila); 2016 Mar 11; 9(3):234-44. PubMed ID: 26667450
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
    Xu S, Jiang C, Lin R, Wang X, Hu X, Chen W, Chen X, Chen T.
    J Exp Clin Cancer Res; 2021 Nov 25; 40(1):373. PubMed ID: 34823564
    [Abstract] [Full Text] [Related]

  • 18. Cordycepin down-regulates multiple drug resistant (MDR)/HIF-1α through regulating AMPK/mTORC1 signaling in GBC-SD gallbladder cancer cells.
    Wu WD, Hu ZM, Shang MJ, Zhao DJ, Zhang CW, Hong DF, Huang DS.
    Int J Mol Sci; 2014 Jul 18; 15(7):12778-90. PubMed ID: 25046749
    [Abstract] [Full Text] [Related]

  • 19. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
    Ma APY, Yeung CLS, Tey SK, Mao X, Wong SWK, Ng TH, Ko FCF, Kwong EML, Tang AHN, Ng IO, Cai SH, Yun JP, Yam JWP.
    Cancer Res; 2021 Jul 01; 81(13):3679-3692. PubMed ID: 33975883
    [Abstract] [Full Text] [Related]

  • 20. Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway.
    Bu HQ, Luo J, Chen H, Zhang JH, Li HH, Guo HC, Wang ZH, Lin SZ.
    Int J Oncol; 2012 Sep 01; 41(3):949-58. PubMed ID: 22710877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.